Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-in-Human Study of a Novel Conformal Pulsed-Field Ablation Balloon Catheter for Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation

NCT07320976 is registered in ClinicalTrials.gov with The Third People's Hospital of Chengdu as lead sponsor.

NCT NCT07320976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07320976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-in-Human Study of a Novel Conformal Pulsed-Field Ablation Balloon Catheter for Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation
Lead sponsor
The Third People's Hospital of Chengdu
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 10, 2024
Completion date
March 15, 2026
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation